The Effect of Different Dosing Schedules of Intravitreal Sirolimus, a Mammalian Target of Rapamycin (mTOR) Inhibitor, in the Treatment of Non-Infectious Uveitis (An American Ophthalmological Society Thesis).
Trans Am Ophthalmol Soc
; 114: T3, 2016 Aug.
Article
em En
| MEDLINE
| ID: mdl-27630374
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Uveíte
/
Sirolimo
/
Serina-Treonina Quinases TOR
Tipo de estudo:
Clinical_trials
/
Diagnostic_studies
/
Guideline
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Female
/
Humans
/
Male
/
Middle aged
País como assunto:
America do norte
Idioma:
En
Ano de publicação:
2016
Tipo de documento:
Article